PTC Therapeutics said this week that it has named Joseph Puglisi to its scientific advisory board.
Puglisi is currently an associate professor of structural biology and director of the Stanford Magnetic Resonance Laboratory at Stanford University School of Medicine, said PTC. His work focuses on the “dynamics of ribosome during translation, the molecular basis for antibiotic action against the ribosome, the mechanism of eukaryotic translation initiation and elongation, the structure and function of the hepatitis C virus internal ribosome, and RNA-protein interactions in the HIV virus,” the company added.
Puglisi received a PhD in biophysical chemistry from the University of California, Berkeley, according to PTC.